Dupilumab long term efficacy in children with moderate-to-severe type 2 asthma with/without evidence of allergic asthma
Phipatanakul W, Prenzel F, Papadopoulos NG, Bacharier LB, Hamelmann E, Fiocchi AG, Altincatal A, Gall R, Ledanois O (2024)
Klinische Pädiatrie 236(02): S3-S4.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Phipatanakul, W.;
Prenzel, F.;
Papadopoulos, N. G.;
Bacharier, L. B.;
Hamelmann, EckardUniBi;
Fiocchi, A. G.;
Altincatal, A.;
Gall, R.;
Ledanois, O.
Erscheinungsjahr
2024
Serien- oder Zeitschriftentitel
Klinische Pädiatrie
Band
236
Ausgabe
02
Seite(n)
S3-S4
ISSN
0300-8630
eISSN
1439-3824
Page URI
https://pub.uni-bielefeld.de/record/2991966
Zitieren
Phipatanakul W, Prenzel F, Papadopoulos NG, et al. Dupilumab long term efficacy in children with moderate-to-severe type 2 asthma with/without evidence of allergic asthma. Klinische Pädiatrie. 2024;236(02):S3-S4.
Phipatanakul, W., Prenzel, F., Papadopoulos, N. G., Bacharier, L. B., Hamelmann, E., Fiocchi, A. G., Altincatal, A., et al. (2024). Dupilumab long term efficacy in children with moderate-to-severe type 2 asthma with/without evidence of allergic asthma. Klinische Pädiatrie, 236(02), S3-S4. https://doi.org/10.1055/s-0044-1779351
Phipatanakul, W., Prenzel, F., Papadopoulos, N. G., Bacharier, L. B., Hamelmann, Eckard, Fiocchi, A. G., Altincatal, A., Gall, R., and Ledanois, O. 2024. “Dupilumab long term efficacy in children with moderate-to-severe type 2 asthma with/without evidence of allergic asthma”, Klinische Pädiatrie, 236 (02): S3-S4.
Phipatanakul, W., Prenzel, F., Papadopoulos, N. G., Bacharier, L. B., Hamelmann, E., Fiocchi, A. G., Altincatal, A., Gall, R., and Ledanois, O. (2024). Dupilumab long term efficacy in children with moderate-to-severe type 2 asthma with/without evidence of allergic asthma. Klinische Pädiatrie 236, S3-S4.
Phipatanakul, W., et al., 2024. Dupilumab long term efficacy in children with moderate-to-severe type 2 asthma with/without evidence of allergic asthma. Klinische Pädiatrie, 236(02), p S3-S4.
W. Phipatanakul, et al., “Dupilumab long term efficacy in children with moderate-to-severe type 2 asthma with/without evidence of allergic asthma”, Klinische Pädiatrie, vol. 236, 2024, pp. S3-S4.
Phipatanakul, W., Prenzel, F., Papadopoulos, N.G., Bacharier, L.B., Hamelmann, E., Fiocchi, A.G., Altincatal, A., Gall, R., Ledanois, O.: Dupilumab long term efficacy in children with moderate-to-severe type 2 asthma with/without evidence of allergic asthma. Klinische Pädiatrie. 236, S3-S4 (2024).
Phipatanakul, W., Prenzel, F., Papadopoulos, N. G., Bacharier, L. B., Hamelmann, Eckard, Fiocchi, A. G., Altincatal, A., Gall, R., and Ledanois, O. “Dupilumab long term efficacy in children with moderate-to-severe type 2 asthma with/without evidence of allergic asthma”. Klinische Pädiatrie 236.02 (2024): S3-S4.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar